Table 1. Pre-operative demographic data and findings of 49 eyes of 49 patients enrolled.
| ID | Age (y) | Gender | Eye | Comorbidity | Previous surgery | PVR | BCVA |
| 1 | 53 | M | L | High myopia | Scleral buckling | Yes | 20/20000 |
| 2 | 54 | F | L | Post-traumatic | PPV+SSO | Yes | 20/20000 |
| 3 | 25 | F | R | Post-traumatic | PPV+SSO | Yes | 20/80 |
| 4 | 60 | M | R | / | PPV+SSO | Yes | 20/80 |
| 5 | 78 | F | R | / | PPV+SSO | Yes | 20/250 |
| 6 | 85 | M | R | / | PPV+SSO | Yes | 20/20000 |
| 7 | 54 | F | L | / | PPV+SSO | Yes | 20/20000 |
| 8 | 70 | M | R | / | Scleral buckling | Yes | 20/250 |
| 9 | 72 | F | L | High myopia | PPV+SSO | Yes | 20/100 |
| 10 | 52 | M | R | / | PPV+SSO | Yes | 20/20000 |
| 11 | 49 | M | L | / | PPV+SSO | Yes | 20/20000 |
| 12 | 42 | M | R | High myopia | PPV+SSO | Yes | 20/80 |
| 13 | 75 | M | L | / | PPV+SSO | Yes | 20/200 |
| 14 | 69 | M | R | / | Scleral buckling | Yes | 20/20000 |
| 15 | 37 | M | R | / | PPV+SSO | Yes | 20/20000 |
| 16 | 43 | M | L | / | PPV+SSO | Yes | 20/250 |
| 17 | 86 | F | R | Post-traumatic | PPV+gas | Yes | 20/20000 |
| 18 | 49 | M | L | Post-traumatic | PPV+SSO | Yes | 20/20000 |
| 19 | 82 | M | R | / | PPV+gas | Yes | 20/20000 |
| 20 | 80 | M | R | / | PPV+SSO | Yes | 20/20000 |
| 21 | 29 | M | L | / | PPV+gas | Yes | 20/20000 |
| 22 | 73 | M | R | / | PPV+SSO | Yes | 20/400 |
| 23 | 58 | M | R | / | PPV+SSO | Yes | 20/20000 |
| 24 | 69 | M | L | Post-traumatic | PPV+SSO | Yes | 20/20000 |
| 25 | 52 | M | R | / | PPV+SSO | Yes | 20/200 |
| 26 | 30 | M | R | Post-traumatic | PPV+SSO | Yes | 20/2000 |
| 27 | 19 | M | R | / | PPV+SSO | Yes | 20/20000 |
| 28 | 66 | M | R | / | Scleral buckling | Yes | 20/200 |
| 29 | 50 | F | R | / | PPV+gas | Yes | 20/32 |
| 30 | 80 | M | L | Post-traumatic | PPV+gas | Yes | 20/100 |
| 31 | 24 | F | L | Post-traumatic | Scleral buckling | Yes | 20/20000 |
| 32 | 71 | M | R | / | Scleral buckling | Yes | 20/400 |
| 33 | 52 | M | R | / | PPV+SSO | Yes | 20/100 |
| 34 | 53 | M | R | / | PPV+SSO | Yes | 20/200 |
| 35 | 38 | F | L | Post-traumatic | PPV+SSO | Yes | 20/100 |
| 36 | 89 | M | R | High myopia | PPV+SSO | Yes | 20/20000 |
| 37 | 45 | M | L | / | PPV+gas | Yes | 20/400 |
| 38 | 64 | M | R | / | PPV+gas | Yes | 20/200 |
| 39 | 54 | M | L | / | PPV+gas | Yes | 20/20000 |
| 40 | 76 | M | L | / | PPV+SSO | Yes | 20/250 |
| 41 | 67 | M | R | Post-traumatic | PPV+SSO | Yes | 20/20000 |
| 42 | 57 | F | R | High myopia | PPV+SSO | Yes | 20/20000 |
| 43 | 81 | M | L | / | PPV+SSO | Yes | 20/20000 |
| 44 | 57 | M | L | Post-traumatic | PPV+SSO | Yes | 20/80 |
| 45 | 60 | M | R | / | PPV+gas | Yes | 20/20000 |
| 46 | 75 | F | R | / | PPV+SSO | Yes | 20/80 |
| 47 | 70 | M | R | / | PPV+SSO | Yes | 20/200 |
| 48 | 61 | M | R | / | Scleral buckling | Yes | 20/250 |
| 49 | 53 | M | L | / | Scleral buckling | Yes | 20/80 |
PPV: Pars plana vitrectomy; SSO: Standard silicon oil; PVR: Proliferative vitreoretinopathy.